 |
 |
The Gloves come off
Pro-Erex. Big Daddy. Suregasm. There is little doubt what these supplements are promising, but the evidence that they actually can enlarge a man's penis or enhance sexual performance falls short, consumer advocates said on Wednesday.
The Center for Science in the Public Interest, best known for taking the fun out of Chinese take-out and ice cream by revealing how unhealthy such treats are, is now taking on the nonprescription sex supplement industry.
The CSPI filed a complaint on Wednesday with the Federal Trade Commission saying one company, Cincinnati-based Berkeley Premium Nutraceuticals, had crossed the line in television ads touting its supplement available at enzyte.com .
"We urge the Federal Trade Commission to immediately enjoin the national television advertisements of Berkeley Premium Nutraceuticals, for the herbal supplement Enzyte," the complaint, faxed to the FTC, reads. "The FTC requires that advertising claims for dietary and herbal supplements, including those based on testimonials of users, 'be backed by sound, scientific evidence.' Berkeley, however, has conceded that it has no scientific studies of Enzyte substantiating any of Berkeley's claims."
Limp Evidence of Penile enlargementThe CSPI says Enzyte, while unusual in its relatively innocuous choice of name, is a fairly typical example of male sexual enhancement supplements.
"It contains tiny amounts of 16 ingredients including familiar herbs like ginkgo and ginseng, the minerals copper and zinc, ... a vitamin (niacin), and an amino acid (arginine)," the CSPI said. According to the company's Web site, enzyte.com it also contains horny goat weed extract and saw palmetto, the latter usually sold as a prostate supplement.
"However, as Enzyte's label says each tablet contains 1,494 mg of its proprietary blend (all ingredients other than niacin, zinc, and copper), it is not possible that Enzyte contains the amounts of those ingredients that may be necessary to improve libido or sexual performance, if, indeed, those ingredients provide a benefit at any dose," the complaint adds.
CSPI spokesman Jeff Cronin said despite the limp evidence that such supplements work, people apparently are buying them. "There's a lot of advertising out there. Advertising is expensive so they must be selling enough to make the ads profitable," he said.
"Enzyte is more successful subtracting from the male wallet than it is enlarging the penis," Schardt said.
Sam Fields
|
 |
 |